The Effect of Informative Letters on the Prescription and Receipt of Seroquel

Abusive prescribing exposes patients to unnecessary health risks and results in wasteful public expenditures. This study will evaluate an innovative approach to fighting abusive prescription: sending letters to suspected inappropriate prescribers warning them that they are outliers compared to their peers and have been flagged for review. The study will target high prescribers of Seroquel (Quetiapine), a commonly prescribed antipsychotic. Using claims data, the researchers will assess the effect of the letters on prescribing of Seroquel, receipt of Seroquel by patients, substitution behavior by prescribers and patients, and health outcomes of patients.

RFP Cycle:
HCDI Off Cycle RFP [2014-2015]
United States of America
  • Project development grant